Michael Cummings

Dr. Michael Cummings, a key figure in California's drug formulary, discusses long-acting injectable antipsychotics (LAIs). He highlights their advantages in improving patient adherence and significantly reducing relapse rates. The conversation covers the transition from oral medications, the importance of individualized dosing, and safety protocols. Cummings also addresses metabolic impacts and weight management strategies, ensuring a comprehensive look at how LAIs enhance psychiatric care. The discussion advocates for better treatment accessibility, particularly for underserved populations.